FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313478887> ?p ?o ?g. }

• W4313478887 endingPage "100527" @default.
• W4313478887 startingPage "100527" @default.
• W4313478887 abstract "<h2>Abstract</h2><h3>Background</h3> Refractory angina (RFA; limiting angina despite optimal medical therapy) is a growing, global problem, with limited treatment options. Therefore, we conducted a systematic review of randomized controlled trials (RCTs) to evaluate the effect of proangiogenic growth factor therapy (in the form of vascular growth factors delivered either as recombinant proteins or gene therapy) in patients with RFA ineligible for revascularization. <h3>Methods</h3> We performed a meta-analysis (PROSPERO: CRD42018107283) of RCTs as per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses methodology. A comprehensive search of the PubMed, CENTRAL, Embase, Cochrane, ClinicalTrials.gov and Google Scholar databases, as well as scientific session abstracts, were performed. The pooled outcomes included major adverse cardiac events (MACE), mortality, myocardial perfusion, and indices of angina severity (Canadian Cardiovascular Society angina class [CCS] and exercise tolerance). A prespecified subgroup analysis was performed for delivery method, vector, and protein type. The standardized mean difference (SMD) or odds ratio (OR) was calculated to assess relevant outcomes. We assessed heterogeneity using the χ² and I² tests. <h3>Results</h3> We included 16 RCTs involving 1607 patients (1052 received proangiogenic growth factor therapy and 555 received a placebo or optimal medical therapy). Our analysis showed a significant decreased risk of MACE (OR, 0.72; 95% confidence interval [CI], 0.55-0.93) and significantly improved CCS class (SMD, −0.55; 95% CI, −1.10 to 0.00), but not mortality (OR, 0.66; 95% CI, 0.28-1.54) or exercise tolerance (SMD, 0.47; 95% CI, −0.14 to 1.09), in treated patients compared to those in the control group. <h3>Conclusions</h3> Proangiogenic growth factor therapy is a promising treatment option for RFA, with beneficial effects seen on MACE and CCS class. The results of ongoing trials are needed before it can be considered for clinical practice." @default.
• W4313478887 created "2023-01-06" @default.
• W4313478887 creator A5007257470 @default.
• W4313478887 creator A5010240121 @default.
• W4313478887 creator A5013961881 @default.
• W4313478887 creator A5014220812 @default.
• W4313478887 creator A5022277596 @default.
• W4313478887 creator A5025528254 @default.
• W4313478887 creator A5027103152 @default.
• W4313478887 creator A5039035285 @default.
• W4313478887 creator A5050124666 @default.
• W4313478887 creator A5055524728 @default.
• W4313478887 creator A5062168421 @default.
• W4313478887 creator A5063210480 @default.
• W4313478887 creator A5080234509 @default.
• W4313478887 creator A5089583715 @default.
• W4313478887 date "2023-01-01" @default.
• W4313478887 modified "2023-10-17" @default.
• W4313478887 title "Proangiogenic Growth Factor Therapy for the Treatment of Refractory Angina: A Meta-analysis" @default.
• W4313478887 cites W122651877 @default.
• W4313478887 cites W1972221671 @default.
• W4313478887 cites W1981459637 @default.
• W4313478887 cites W1982688102 @default.
• W4313478887 cites W1988177733 @default.
• W4313478887 cites W1993966328 @default.
• W4313478887 cites W1995490331 @default.
• W4313478887 cites W2014855350 @default.
• W4313478887 cites W2018236556 @default.
• W4313478887 cites W2025110798 @default.
• W4313478887 cites W2039337359 @default.
• W4313478887 cites W2042712894 @default.
• W4313478887 cites W2051206599 @default.
• W4313478887 cites W2053706156 @default.
• W4313478887 cites W2098923148 @default.
• W4313478887 cites W2103227975 @default.
• W4313478887 cites W2115260446 @default.
• W4313478887 cites W2124715674 @default.
• W4313478887 cites W2134833483 @default.
• W4313478887 cites W2136812723 @default.
• W4313478887 cites W2138369468 @default.
• W4313478887 cites W2151832908 @default.
• W4313478887 cites W2152843042 @default.
• W4313478887 cites W2159376400 @default.
• W4313478887 cites W2160414137 @default.
• W4313478887 cites W2162844134 @default.
• W4313478887 cites W2333043019 @default.
• W4313478887 cites W2741933191 @default.
• W4313478887 cites W2883681062 @default.
• W4313478887 cites W2928553041 @default.
• W4313478887 cites W3021808893 @default.
• W4313478887 cites W3113832800 @default.
• W4313478887 cites W3128350662 @default.
• W4313478887 cites W3179781533 @default.
• W4313478887 cites W4210992712 @default.
• W4313478887 doi "https://doi.org/10.1016/j.jscai.2022.100527" @default.
• W4313478887 hasPublicationYear "2023" @default.
• W4313478887 type Work @default.
• W4313478887 citedByCount "1" @default.
• W4313478887 countsByYear W43134788872023 @default.
• W4313478887 crossrefType "journal-article" @default.
• W4313478887 hasAuthorship W4313478887A5007257470 @default.
• W4313478887 hasAuthorship W4313478887A5010240121 @default.
• W4313478887 hasAuthorship W4313478887A5013961881 @default.
• W4313478887 hasAuthorship W4313478887A5014220812 @default.
• W4313478887 hasAuthorship W4313478887A5022277596 @default.
• W4313478887 hasAuthorship W4313478887A5025528254 @default.
• W4313478887 hasAuthorship W4313478887A5027103152 @default.
• W4313478887 hasAuthorship W4313478887A5039035285 @default.
• W4313478887 hasAuthorship W4313478887A5050124666 @default.
• W4313478887 hasAuthorship W4313478887A5055524728 @default.
• W4313478887 hasAuthorship W4313478887A5062168421 @default.
• W4313478887 hasAuthorship W4313478887A5063210480 @default.
• W4313478887 hasAuthorship W4313478887A5080234509 @default.
• W4313478887 hasAuthorship W4313478887A5089583715 @default.
• W4313478887 hasBestOaLocation W43134788871 @default.
• W4313478887 hasConcept C126322002 @default.
• W4313478887 hasConcept C142424586 @default.
• W4313478887 hasConcept C143998085 @default.
• W4313478887 hasConcept C191897082 @default.
• W4313478887 hasConcept C192562407 @default.
• W4313478887 hasConcept C2778425758 @default.
• W4313478887 hasConcept C500558357 @default.
• W4313478887 hasConcept C71924100 @default.
• W4313478887 hasConcept C95190672 @default.
• W4313478887 hasConceptScore W4313478887C126322002 @default.
• W4313478887 hasConceptScore W4313478887C142424586 @default.
• W4313478887 hasConceptScore W4313478887C143998085 @default.
• W4313478887 hasConceptScore W4313478887C191897082 @default.
• W4313478887 hasConceptScore W4313478887C192562407 @default.
• W4313478887 hasConceptScore W4313478887C2778425758 @default.
• W4313478887 hasConceptScore W4313478887C500558357 @default.
• W4313478887 hasConceptScore W4313478887C71924100 @default.
• W4313478887 hasConceptScore W4313478887C95190672 @default.
• W4313478887 hasIssue "1" @default.
• W4313478887 hasLocation W43134788871 @default.
• W4313478887 hasOpenAccess W4313478887 @default.
• W4313478887 hasPrimaryLocation W43134788871 @default.
• W4313478887 hasRelatedWork W2351796763 @default.

• next